Here are three notes:
1. The shares were sold at $38.28 per share for a total value of $62.43 million.
2. Conmed’s 52-week high is $60.662 and the 52-week low is $35.51.
3. The company has a market cap of $1.03 billion.
More articles on devices:
Materialise, Mathys pen agreement — 4 highlights
Amedica to present clinical trial for CASCADE — 5 notes
Arthrex named one of Fortune’s 15 best workplaces for production: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
